Submitted by Anonymous (not verified) on 7 July 2026 - 14:36
Opinion/decision on a Paediatric investigation plan (PIP): Juluca, rilpivirine hydrochloride,dolutegravir sodium, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infections and infestations, PIP number: EMA/PE/0000240971
Source:
